Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

June 21, 2022

Primary Completion Date

February 28, 2027

Study Completion Date

February 28, 2029

Conditions
Colorectal Cancer
Interventions
OTHER

Observation

No intervention

Trial Locations (20)

17403

RECRUITING

Cancer Care Associates of York, York

20817

RECRUITING

The Center for Cancer and Blood Disorders, Bethesda

27543

RECRUITING

Southeastern Medical Oncology Center, Goldsboro

43210

RECRUITING

Ohio State University, Columbus

43214

RECRUITING

OhioHealth Research Institute, Columbus

43623

RECRUITING

Toledo Clinic Cancer Center, Toledo

44710

RECRUITING

Aultman Hospital, Canton

45220

RECRUITING

TriHealth Cancer Institute, Cincinnati

54911

RECRUITING

ThedaCare Regional Cancer Center, Appleton

63110

RECRUITING

Washington University School of Medicine, St Louis

63128

RECRUITING

Mercy Clinic Oncology and Hematology - Sindelar Cancer Center, St Louis

63141

RECRUITING

Mercy Clinic Oncology and Hematology - David C. Pratt Cancer Center, St Louis

64804

RECRUITING

Mercy Clinic Oncology and Hematology - Joplin, Joplin

65804

RECRUITING

Mercy Clinic Cancer and Hematology - Chub O'Reilly Cancer Center, Springfield

68130

RECRUITING

Nebraska Cancer Specialists, Omaha

72903

RECRUITING

Mercy Clinic Oncology - Fort Smith, Fort Smith

73120

RECRUITING

Mercy Clinic Oncology and Hematology - Coletta, Oklahoma City

84124

RECRUITING

Utah Cancer Specialists, Salt Lake City

92708

RECRUITING

MemorialCare, Fountain Valley

98109

RECRUITING

University of Washington / Fred Hutchinson Cancer Center, Seattle

All Listed Sponsors
lead

Tempus AI

INDUSTRY